Healstra is a specialized digital health and strategic consulting firm focused on Market Access and Health Economics and Outcomes Research (HEOR). The company leverages advanced Artificial Intelligence and Generative AI to optimize clinical research methodologies and demonstrate the value of healthcare innovations to payers and regulatory bodies. Healstra provides pharmaceutical and biotech companies with robust evidence-generation tools, particularly focusing on Real-World Evidence (RWE) derived from the French National Health Insurance database (SNDS). Their solutions aim to bridge the gap between clinical efficacy and economic value, facilitating faster and more sustainable patient access to new therapies.
CLASSIFICATION
Company Type:Digital Health
Industry:Digital Health
Sub-Industry:HEOR & Market Access Consulting
SIZE & FINANCIALS
Employees:1-50
Revenue:<$1M (Estimated)
Founded:2024
Ownership:private
Status:operating
FUNDING
Stage:Seed
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service/Software Provider)
Modalities:Digital Health Software, AI-driven Analytics, RWE Platforms
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:French National Health Insurance (SNDS data access), Academic researchers in Oncology (Multiple Myeloma studies), Public Health agencies (Respiratory vaccine white papers)
COMPETITION
Position:Emerging
Competitors:OPEN Health, Analysis Group, Fortrea (Market Access division), Icon plc (HEOR division), Quantify Research
LEADERSHIP
Key Executives:
Ludovic Lamarsalle - Founder & CEO
Scientific Founders:Ludovic Lamarsalle
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Healstra. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.